Parsippany-Troy Hills, N.J.-based Allergan earned approval from the Food and Drug Administration for its Natrelle Inspira SoftTouch breast implant, reports MassDevice.
The implant is designed for use in breast reconstruction, augmentation or revision surgeries and was created using a new gel to achieve medium firmness.
The approval marks the third firmness option for Allergan's breast implant portfolio.
More articles on supply chain:
Why driverless cars could magnify the organ donor shortage
Amazon's newest endeavor: A floating warehouse
How 'phantom inventory' could be hurting your supply chain